Stockscreener 앱 받기
5.33
4.65%
-0.26
시장 영업 전:
5.34
0.010
+0.19%
전일 마감가:
$5.59
열려 있는:
$5.59
하루 거래량:
928.22K
Relative Volume:
1.25
시가총액:
$220.64M
수익:
$134.48M
순이익/손실:
$-38.94M
주가수익비율:
-5.5905
EPS:
-0.9534
순현금흐름:
$-19.34M
1주 성능:
-12.41%
1개월 성능:
-21.73%
6개월 성능:
-53.33%
1년 성능:
-67.16%
1일 변동 폭
$5.31
$5.6655
1주일 범위
$5.31
$6.15
52주 변동 폭
$5.30
$16.36
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
5.33 | 231.41M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 개시 | William Blair | Mkt Perform |
| 2025-07-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-07-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-07-09 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | 개시 | Piper Sandler | Neutral |
| 2025-04-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-04 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-04-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-10-29 | 개시 | Jefferies | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-05-07 | 재확인 | BTIG Research | Buy |
| 2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 개시 | Morgan Stanley | Overweight |
| 2023-04-13 | 개시 | Oppenheimer | Outperform |
| 2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight Inc stock (US78419L1008): Nasdaq-listed eye-care specialist in focus after recent price weak - AD HOC NEWS
RxSight Securities Lawsuit Advances After Court Denies Dismissal Bid - TipRanks
Midday Stock Roundup: TTM Drops on Investor Day - Orange County Business Journal
RxSight Must Litigate Investor Suit Over Eye Lens System Demand - Bloomberg Law News
Avoiding Lag: Real-Time Signals in (RXST) Movement - Stock Traders Daily
RxSight Inc. Q1 2026 Earnings: EPS Misses Estimates Amid Operational HeadwindsOne-Time Loss Impact - Newser
RxSight Q1 2026 Earnings: EPS Misses Estimates by 32% as Operational Costs WeighQuarterly Earnings Report - Newser
RxSight to present at Stifel 2026 Virtual Ophthalmology Forum on May 26 - Pluang
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum - The Manila Times
RxSight stock (US78419L1008): Q1 revenue dip and share slide put growth story to the test - AD HOC NEWS
Tarsus, RxSight Fall Despite Growth Signals - Orange County Business Journal
RxSight stock (US78419L1008): FDA-linked growth and execution stay in focus - AD HOC NEWS
RxSight stock (US78419L1008): FDA-backed growth story stays in focus - AD HOC NEWS
Number of shareholders of RxSight, Inc. – NASDAQ:RXST - TradingView
Discipline and Rules-Based Execution in RXST Response - Stock Traders Daily
RxSight Earnings Call Balances Growth With Headwinds - TipRanks
TradingKey - TradingKey
BofA Securities Maintains RxSight(RXST.US) With Sell Rating - Moomoo
RXST: Stable Q1 results and ongoing commercial initiatives support sequential growth and global expansion - TradingView
Artisan Partners reports 5.0% stake in RxSight (NASDAQ: RXST) - Stock Titan
Midday Stock Roundup: Skyworks Solutions Falls - Orange County Business Journal
RxSight (RXST) Q1 2026 Earnings Transcript - AOL.com
RxSight, Inc. (NASDAQ:RXST) Q1 2026 Earnings Call Transcript - Insider Monkey
RxSight (RXST) Gets a Hold from Stifel Nicolaus - The Globe and Mail
William Blair Maintains RxSight(RXST.US) With Hold Rating - Moomoo
RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook - VisionMonday.com
Piper Sandler Maintains RxSight(RXST.US) With Hold Rating, Maintains Target Price $10 - Moomoo
RxSight, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
RxSight Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: RxSight beats Q1 2026 forecasts, stock dips By Investing.com - Investing.com Australia
RXST: Q1 revenue fell 18% year-over-year, but LAL volumes stabilized and gross margin improved - TradingView
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Rxsight Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: RxSight beats Q1 2026 forecasts, stock dips - Investing.com
RxSight (NASDAQ:RXST) Q1 2026 Results: Revenue Beats but Loss Widens Amid Cautious Market Reaction - ChartMill
RxSight, Inc. (RXST) Tops Q1 EPS by 12c - StreetInsider
RxSight (RXST) Q1 2026 revenue drops 18.5% as net loss nearly doubles - Stock Titan
Eye-lens maker RxSight says sales slowed, but kept 2026 target - Stock Titan
RxSight, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
RxSight (NASDAQ: RXST) posts wider Q1 loss but keeps 2026 sales outlook - Stock Titan
How many employees work at RxSight? - Revelio Labs
symbol__ Stock Quote Price and Forecast - CNN
Rxsight Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Behavioral Patterns of RXST and Institutional Flows - Stock Traders Daily
How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets - Yahoo! Finance Canada
Earnings Preview: RxSight to Report Financial Results Post-market on May 06 - Moomoo
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.59%
1.94%
자본화:
|
볼륨(24시간):